International_Federation_of_Pharmaceutical_Manufacturers_and_Associations
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)[2] is a trade association that represents internationally over 90 leading innovative pharmaceutical companies and associations around the world. IFPMA is based in Geneva and is in official relations with the United Nations[3] where it contributes industry expertise to global health discussions.
 |
It was formed in 1968 and is based in Geneva, Switzerland.[4]
In 2019, IFPMA released a strengthened code of ethics[5] and professional standards.[6] Among the revisions to the code is a prohibition on gifts provided to healthcare professionals.[7] The code revision has been followed by Ethoscope[8] – an open-source, continuously evolving resource that contains diverse guidance designed to keep pace with emerging developments.
The pharmaceutical industry contributes to the Sustainable Development Goals (SDGs), in particular Goal 3 to ensure healthy lives and promote well-being for all at all ages.[9] Today over 35 IFPMA member companies contribute resources and knowhow to SDG initiatives [10] partnering with academia, development organizations, NGOs, foundations and other business sectors. There are over 250 collaborations that aim to strengthen health systems and expand quality healthcare access.[11]
IFPMA works in partnership with other members of the global health community to achieve Universal Health Coverage (UHC) targets and contribute to a world where no one is left behind in receiving the healthcare they need.[12] A wide range of stakeholders across the public and private sectors have an opportunity to collaborate more closely to increase affordability of and access to essential medicines, and the low-cost, but highly effective, interventions and screenings.[13]
